Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts

Wound Repair and Regeneration

Volumn 9, Issue 4, 2001, Pages 314-322

  Weckroth, Miina ^a   Vaheri, Antti ^a   Myöhänen, Heli ^a   Tukiainen, Erkki ^b   Sirén, Vappu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LEG ULCER; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; SPLIT THICKNESS SKIN GRAFT; WOUND HEALING;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; BODY FLUIDS; CELLS, CULTURED; CHRONIC DISEASE; EXUDATES AND TRANSUDATES; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; LEG ULCER; MALE; MIDDLE AGED; MODELS, THEORETICAL; RECEPTORS, CELL SURFACE; SENSITIVITY AND SPECIFICITY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034797402     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2001.00314.x     Document Type: Article

References (48)

1. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds
2. Biochemical and antibacterial analysis of human wound and blister fluid
3. Proteolytic activity in leg ulcer exudate
4. Matrix metalloproteinases, gelatinase and collagenase in chronic leg ulcers
5. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9
6. Inhibition of cell proliferation by chronic wound fluid
7. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth
8. Serum is a potent stimulator of keratinocyte tissue plasminogen activator expression
9. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system
10. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo
11. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds
12. The urokinase-type plasminogen activator system in cancer metastasis: A review
13. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds
14. Impaired wound healing in mice with a disrupted plasminogen gene
15. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro
16. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
17. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
18. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
19. Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator
20. 2-terminal portion of the smaller fragment released from both collagens
21. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: Prognostic relevance and target for therapy
22. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
23. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated adhesion and release?
24. The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
25. Regulation of integrin function by the urokinase receptor
26. Requirement of receptor bound urokinase-type plasminogen activator for integrin αvβ5-directed migration
27. Microplate immunocapture assay for plasminogen activators and their specific inhibitors
28. Plasminogen: Purification from human plasma by affinity chromatography
29. Thiobenzyl benzyloxycarbonyl-L-lysinate, substrate for a colorimetric assay for trypsin-like enzymes
30. Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies
31. Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay
32. Human endothelial cells contain one type of plasminogen activator
33. 2 terminal domain of the urokinase receptor
34. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers
35. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers
36. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α1-proteinase inhibitor, and α2-macroglobulin
37. Collagenase-1 complexes with α2-macroglobulin in the acute and chronic wound environments
38. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors
39. Fibronectin profiles in normal and chronic wound fluid
40. The in vitro response of fibroblasts to the fluid that accumulates under a vapor-permeable membrane
41. Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting, and cell adhesion assays
42. Growth factors and wound healing: Part II. Role in normal and chronic wound healing
43. Urokinase and tissue type plasminogen activators in human keratinocyte culture
44. Plasminogen activation in healing human wounds
45. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface
46. Cancer invasion and tissue remodelling: Common themes in proteolytic matrix degradation
47. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
48. Plasminogen activation on the cell surface: A functional crossroad of cell migration-associated pathways